Hope T - Search Results

1

Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging.

White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale AM. White NS, et al. Among authors: hope t. Cancer Res. 2014 Sep 1;74(17):4638-52. doi: 10.1158/0008-5472.CAN-13-3534. Cancer Res. 2014. PMID: 25183788 Free PMC article. Review.

2

Demonstration of Non-Gaussian Restricted Diffusion in Tumor Cells Using Diffusion Time-Dependent Diffusion-Weighted Magnetic Resonance Imaging Contrast.

Hope TR, White NS, Kuperman J, Chao Y, Yamin G, Bartch H, Schenker-Ahmed NM, Rakow-Penner R, Bussell R, Nomura N, Kesari S, Bjørnerud A, Dale AM. Hope TR, et al. Front Oncol. 2016 Aug 2;6:179. doi: 10.3389/fonc.2016.00179. eCollection 2016. Front Oncol. 2016. PMID: 27532028 Free PMC article.

3

Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.

Hope TR, Selnes P, Rektorová I, Anderkova L, Nemcova-Elfmarkova N, Balážová Z, Dale A, Bjørnerud A, Fladby T. Hope TR, et al. PLoS One. 2019 May 31;14(5):e0217922. doi: 10.1371/journal.pone.0217922. eCollection 2019. PLoS One. 2019. PMID: 31150514 Free PMC article.

4

Serial diffusion tensor imaging for early detection of radiation-induced injuries to normal-appearing white matter in high-grade glioma patients.

Hope TR, Vardal J, Bjørnerud A, Larsson C, Arnesen MR, Salo RA, Groote IR. Hope TR, et al. J Magn Reson Imaging. 2015 Feb;41(2):414-23. doi: 10.1002/jmri.24533. Epub 2014 Jan 8. J Magn Reson Imaging. 2015. PMID: 24399480

5

The effect of gradient sampling schemes on diffusion metrics derived from probabilistic analysis and tract-based spatial statistics.

Hope T, Westlye LT, Bjørnerud A. Hope T, et al. Magn Reson Imaging. 2012 Apr;30(3):402-12. doi: 10.1016/j.mri.2011.11.003. Epub 2012 Jan 13. Magn Reson Imaging. 2012. PMID: 22244542

6

Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.

Larsson C, Groote I, Vardal J, Kleppestø M, Odland A, Brandal P, Due-Tønnessen P, Holme SS, Hope TR, Meling TR, Fosse E, Emblem KE, Bjørnerud A. Larsson C, et al. Magn Reson Imaging. 2020 May;68:106-112. doi: 10.1016/j.mri.2020.01.012. Epub 2020 Jan 28. Magn Reson Imaging. 2020. PMID: 32004711 Free article.

7

Diagnostic utility of Restriction Spectrum Imaging in the characterization of the peritumoral brain zone in glioblastoma: Analysis of overall and progression-free survival.

Latysheva A, Geier OM, Hope TR, Brunetti M, Micci F, Vik-Mo EO, Emblem KE, Server A. Latysheva A, et al. Eur J Radiol. 2020 Nov;132:109289. doi: 10.1016/j.ejrad.2020.109289. Epub 2020 Sep 18. Eur J Radiol. 2020. PMID: 33002815 Free article.

8

Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer.

Emmett L, Papa N, Hope TA, Fendler W, Calais J, Burger I, Eiber M, Barbato F, Moon D, Counter W, John N, Xue A, Franklin A, Thompson J, Rasiah K, Frydenberg M, Yaxley J, Buteau J, Agrawal S, Ho B, Nguyen A, Liu V, Lee J, Woo H, Hsiao E, Sutherland T, Perry E, Stricker P, Hofman MS, Kasivisvanathan V, Roberts M, Murphy D. Emmett L, et al. Among authors: hope ta. J Urol. 2024 May 21:101097JU0000000000004010. doi: 10.1097/JU.0000000000004010. Online ahead of print. J Urol. 2024. PMID: 38758680

9

Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases.

Nakayama M, Hope TA, Salavati A. Nakayama M, et al. Among authors: hope ta. Cancer J. 2024 May-Jun 01;30(3):210-217. doi: 10.1097/PPO.0000000000000719. Cancer J. 2024. PMID: 38753756 Review.

10

PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy.

Oldan JD, Almaguel F, Voter AF, Duran A, Gafita A, Pomper MG, Hope TA, Rowe SP. Oldan JD, et al. Among authors: hope ta. Cancer J. 2024 May-Jun 01;30(3):176-184. doi: 10.1097/PPO.0000000000000718. Cancer J. 2024. PMID: 38753752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

747 results

Search Page